c-Ha-ras not c-Ki-ras activation in three colon tumour cell lines

Carcinogenesis
|October 1, 1985
PubMed

Insights

Researchers identified an activated c-Ha-ras gene in colon carcinoma cell lines. This gene showed a mutation, leading to an altered protein product in invasive adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colon carcinoma is a significant health concern.
  • Ras genes play a crucial role in cell growth and cancer development.
  • Identifying specific genetic alterations in cancer is key to understanding its progression.

Purpose of the Study:

  • To identify activated oncogenes in early-passage colon carcinoma cell lines.
  • To characterize the genetic and protein alterations in the c-Ha-ras gene within these cell lines.

Main Methods:

  • Utilized the NIH 3T3 transformation assay system.
  • Isolated and analyzed early passage colon carcinoma cell lines.
  • Examined the DNA coding sequence and protein product of the c-Ha-ras gene.

Main Results:

  • An activated c-Ha-ras transforming gene was identified in three distinct colon carcinoma cell lines.
  • The p21 c-Ha-ras gene product exhibited altered electrophoretic mobility.
  • A point mutation in the DNA coding sequence resulted in an amino acid substitution at position 12.

Conclusions:

  • The activated c-Ha-ras gene is implicated in the development of invasive, differentiated colon adenocarcinoma.
  • Specific mutations in c-Ha-ras can lead to altered protein function, contributing to tumorigenesis.
  • These findings highlight the importance of ras gene mutations in colon cancer.